Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
32.20
+0.40 (1.26%)
Sep 5, 2025, 5:00 PM CET
1.26%
Market Cap591.05M
Revenue (ttm)359.79M
Net Income (ttm)-4.95M
Shares Out18.36M
EPS (ttm)-0.27
PE Ration/a
Forward PE77.75
Dividendn/a
Ex-Dividend Daten/a
Volume63,187
Average Volume25,007
Open31.80
Previous Close31.80
Day's Range30.60 - 33.20
52-Week Range26.50 - 65.60
Beta0.07
RSI50.93
Earnings DateSep 12, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.